WASHINGTON--(BUSINESS WIRE)--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Humana Inc. (“Humana” or the “Company”) (NYSE:HUM), concerning the Company’s proposed acquisition by Aetna Inc. Under the terms of the proposal, Humana shareholders will receive $125.00 in cash and 0.8375 Aetna common shares for each share of Humana common stock they own or $230.11 per share. The entire transaction is valued at approximately $37 billion. The investigation is focu
| < Prev | Next > |
|---|
